Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Increased Incidence of Chronic Graft-Versus-Host Disease (GVHD) and No Survival Advantage with Filgrastim-Mobilized Peripheral Blood Stem Cells (PBSC) Compared to Bone Marrow (BM) Transplants From Unrelated Donors: Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0201, a Phase III, Prospective, Randomized Trial 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Anasetti, C., Logan, B. R., Lee, S. J., Waller, E. K., Weisdorf, D. J., Wingard, J. R., Cutler, C. S., Westervelt, P., Woolfrey, A., Couban, S., Johnston, L., Maziarz, R. T., Pulsipher, M., Anderlini, P., Bensinger, W. I., Leitman, S. F., Rowley, S. D., Carter, S. L., Horowitz, M. M., Confer, D. L. AMER SOC HEMATOLOGY. 2011: 3–3
View details for Web of Science ID 000299597100002